» Articles » PMID: 10579980

Direct Ex Vivo Analysis of Hepatitis B Virus-specific CD8(+) T Cells Associated with the Control of Infection

Overview
Specialty Gastroenterology
Date 1999 Dec 2
PMID 10579980
Citations 132
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Cytotoxic T cells have been suggested to be responsible for lysis of hepatitis B virus (HBV)-infected hepatocytes and control of virus infection. The frequency, kinetics, phenotype, and capacity for clonal expansion of circulating HBV-specific CD8 cells were analyzed directly in patients with acute HBV infection to clarify their pathogenetic role.

Methods: Three HLA-A2 peptide tetramers able to visualize HBV core, envelope, and polymerase epitope-specific cytotoxic T lymphocytes were synthesized and used for flow cytometric analysis of antigen-specific populations.

Results: Tetramer-positive cells specific for the core 18-27 epitope were found at a higher frequency than those specific for polymerase 575-583 and envelope 335-343 epitopes in most patients with acute HBV. The number of HBV-specific CD8 cells was highest during the clinically acute stage of infection and decreased after recovery. These cells expressed an activated phenotype and had an impaired capacity to expand in vitro and to display cytolytic activity in response to peptide stimulation. Recovery of these functions was observed when the frequency of specific CD8 cells decreased, coincident with a progressive decrease in their expression of activation markers.

Conclusions: This study provides the first ex vivo evidence that the highest frequency of circulating HBV-specific CD8 cells coincides with the clinically acute phase of hepatitis B. These cells exhibit an activated phenotype with limited further proliferative capacity that is restored during recovery.

Citing Articles

Cell-type-specific expression analysis of liver transcriptomics with clinical parameters to decipher the cause of intrahepatic inflammation in chronic hepatitis B.

Wang J, Li Q, Qiu Y, Kitanovski S, Wang C, Zhang C Imeta. 2024; 3(4):e221.

PMID: 39135698 PMC: 11316924. DOI: 10.1002/imt2.221.


Optimized Ex Vivo Fluorospot Assay to Measure Multifunctional HBV-Specific T Cell Frequencies in Chronic Hepatitis B Patients.

Chua C, Garcia-Lopez M, Gehring A Methods Mol Biol. 2024; 2837:227-240.

PMID: 39044089 DOI: 10.1007/978-1-0716-4027-2_20.


KLRG1-expressing CD8+ T cells are exhausted and polyfunctional in patients with chronic hepatitis B.

Wang L, Liao F, Yang L, Jiang L, Duan L, Wang B PLoS One. 2024; 19(5):e0303945.

PMID: 38776335 PMC: 11111010. DOI: 10.1371/journal.pone.0303945.


Single-cell RNA-sequencing of virus-specific cellular immune responses in chronic hepatitis B patients.

Hatje K, Kam-Thong T, Giroud N, Saviano A, Simo-Noumbissie P, Kumpesa N Sci Data. 2024; 11(1):355.

PMID: 38589415 PMC: 11001867. DOI: 10.1038/s41597-024-03187-2.


HBsAg level defines different clinical phenotypes of HBeAg(-) chronic HBV infection related to HBV polymerase-specific CD8 cell response quality.

Pena-Asensio J, Calvo-Sanchez H, Miquel-Plaza J, Sanz-de-Villalobos E, Gonzalez-Praetorius A, Delgado-Fernandez A Front Immunol. 2024; 15:1352929.

PMID: 38545116 PMC: 10966405. DOI: 10.3389/fimmu.2024.1352929.